Department of Neurology, University Hospital of Ioannina, Ioannina, Greece.
Department of Neurology, University Hospital of Larissa, Larissa, Greece.
Lab Med. 2022 Mar 7;53(2):210-214. doi: 10.1093/labmed/lmab060.
The advent of next generation sequencing has revolutionized diagnostic approaches to hereditary polyneuropathies. Recently, mutations on the membrane metallo-endopeptidase (MME) gene, encoding neprilysin, have been related to the development of late-onset Charcot-Marie-Tooth disease type 2 (CMT2). Here, we report the first Greek patient presenting with a slowly progressive late-onset axonal polyneuropathy and a novel, likely pathogenic, heterozygous variant in the MME gene. In addition, we have performed a systematic review of all published case reports of patients with MME mutations. The results of the studies show that MME variants can be inherited as both fully penetrant autosomal-recessive and incompletely penetrant autosomal-dominant traits. A number of heterozygous variants characterized as incompletely penetrant impose an increased risk of developing a CMT2-like phenotype late in life, identical to the case study described here. Greater mutation numbers in different populations and mutation-specific functional studies will be essential to identify the pathogenicity and inheritance of more MME variants.
下一代测序的出现彻底改变了遗传性多发性神经病的诊断方法。最近,编码 Neprilysin 的膜金属内肽酶 (MME) 基因的突变与迟发性夏科-马里-图病 2 型 (CMT2) 的发展有关。在这里,我们报告了首例希腊患者,其表现为进行性缓慢的迟发性轴索性多发性神经病,以及 MME 基因中的一种新的、可能具有致病性的杂合变异。此外,我们对所有已发表的 MME 突变患者病例报告进行了系统回顾。研究结果表明,MME 变体可以作为完全外显的常染色体隐性遗传和不完全外显的常染色体显性遗传特征遗传。一些被描述为不完全外显的杂合变体增加了晚年发展出类似 CMT2 表型的风险,与这里描述的病例研究相同。不同人群中更多的突变数量和突变特异性功能研究对于确定更多 MME 变体的致病性和遗传方式至关重要。